Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
330 participants
INTERVENTIONAL
2014-05-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
NCT00235690
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668
Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria
NCT01060891
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961
Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
NCT00300560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Dose Colistin
High dose colistin protocol
High Dose Colistin
High Dose Colistin
Standard Dose Colistin
Standard dose of colistin
Standard Dose Colistin
Standard Dose Colistin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Dose Colistin
High Dose Colistin
Standard Dose Colistin
Standard Dose Colistin
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has clinical signs and symptoms of infection with suspected or proven infection due to Carbapenem resistant microorganism.
3. Patient was started with Empirical therapy of Colistin and positive MDRO within 5 days of empirical therapy.
Exclusion Criteria
2. Pregnant patient.
3. If received Colistin treatment for less than 72 hours.
4. Renal Replacement Therapy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Saud Medical City
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed F Mady, PhD
Role: PRINCIPAL_INVESTIGATOR
King Saud Medical City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Saud Medical City
Riyadh, Riyadh Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Basheer M Abdelrahman, pharmD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSMC-CCD-AFM-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.